Ownership and insider activity for BioRestorative Therapies, Inc. (BRTX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100.
Price
| Price | $2.55 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31822 | $451680 | $117523 | $1664 | $3.1M | $21.0M | $1.7M | $884377 | $547890 | $1.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | $13.0M | $10.2M | $10.2M | $1.4M |
| Receivables | $6000 | $38000 | $29000 | $32000 | $17000 | $5000 | $16000 | $19300 | $188400 | $15500 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $61676 | $519710 | $180987 | $68863 | $3.2M | $21.5M | $15.1M | $11.4M | $11.1M | $3.1M |
| Property, Plant & Equipment | $508594 | $327847 | $175235 | $658296 | $495763 | $395798 | $502762 | $507502 | $362936 | $358767 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $963845 | $888950 | $814059 | $739164 | $664268 | $589740 | $803438 | $713692 | $623945 | $534198 |
| Total Assets | $1.6M | $1.8M | $1.2M | $1.5M | $4.3M | $22.5M | $16.4M | $12.6M | $12.3M | $4.1M |
| Accounts Payable | $2.3M | $2.5M | $1.9M | $2.0M | $118851 | $50827 | $170902 | $189389 | $483070 | $1.3M |
| Short-term Debt | $1.9M | $3.5M | $3.6M | $7.2M | 0 | $58970 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $5.8M | $8.4M | $9.3M | $13.7M | $1.0M | $363822 | $6.0M | $2.6M | $3.7M | $3.7M |
| Long-term Debt | $297756 | $194282 | $523894 | 0 | $4.3M | $191030 | 0 | 0 | 0 | 0 |
| Total Liabilities | $6.6M | $8.6M | $9.8M | $14.2M | $5.7M | $856497 | $6.1M | $2.6M | $3.7M | $3.7M |
| Retained Earnings | -$42.0M | -$51.4M | -$63.9M | -$78.6M | -$89.8M | -$134.1M | -$136.3M | -$146.7M | -$155.7M | -$169.9M |
| Total Equity | -$5.0M | -$6.8M | -$8.6M | -$12.8M | -$1.3M | $21.6M | $10.3M | $10.0M | $8.5M | $356744 |
| Total Debt | $2.2M | $3.7M | $4.1M | $7.8M | $4.8M | $670700 | $301645 | $162317 | 0 | 0 |
| Net Debt | $2.1M | $3.2M | $4.0M | $7.8M | $1.7M | -$20.4M | -$14.4M | -$10.9M | -$10.7M | -$3.0M |
| Working Capital | -$5.8M | -$7.8M | -$9.1M | -$13.7M | $2.1M | $21.1M | $9.1M | $8.8M | $7.4M | -$586029 |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 2.35 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -69.34 |
Profitability
| Return on Equity | -423.84% |
| Return on Invested Capital | -464.86% |
| Return on Assets | -238.27% |
| Gross Margin | 92.09% |
| Operating Margin | -3975.00% |
| Net Margin | -3089.55% |
Related companies: BOLT · COCP · DWTX · EDSA · EVGN · IMNN · IMRN
Explore sector: Healthcare · Biotechnology
More sections of BRTX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks